No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

Representatives of Moderna Biotech UK and NHS England will also be questioned by the inquiry, led by crossbench peer Baroness ...

Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...

As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, it's natural ...

Moderna (MRNA) stock gained in the premarket after the company received a tender to supply its COVID-19 vaccine in the EU, ...

While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...

Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021. Trump will reinstate members of the U.S.

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain ...

As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.

The amended lawsuit, filed in July 2022, sought a court order requesting that the agency reconsider granting authorization ...

it's easy to write off Moderna (NASDAQ: MRNA) as a biotech that'll never recover its former glory -- which it built on the success of its coronavirus vaccine program. In that vein, let's learn ...

Robert F. Kennedy Jr. made claims during his Senate confirmation hearing on issues including vaccines, pesticides and Lyme ...